Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats

International Immunopharmacology

Volumn 30, Issue , 2016, Pages 157-162

  Xiong, Deqing ^a   Deng, Yuanyuan ^a   Huang, Bin ^a   Yin, Caixia ^a   Liu, Bo ^a   Shi, Jingshan ^a   Gong, Qihai ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Icariin; Inflammation; Nuclear factor B; Peroxisome proliferator activated receptor

Indexed keywords

I KAPPA B ALPHA; ICARIIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; EPIMEDII FLAVONE; FLAVONOID; HERBACEOUS AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING; ANIMAL; GENETICS; HUMAN; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM;

ANIMALS; BRAIN ISCHEMIA; DRUGS, CHINESE HERBAL; FLAVONOIDS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1BETA; MALE; NEUROPROTECTION; NF-KAPPA B; PPAR ALPHA; PPAR GAMMA; RATS; REPERFUSION INJURY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84949034208     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.11.035     Document Type: Article

References (50)

1. A. Green Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly Br. J. Pharmacol. 153 2008 S325 S328
2. H.S. Friedman, W. Koroshetz, and N. Qureshi Tissue plasminogen activator for acute ischemic stroke N. Engl. J. Med. 334 1996 1405
3. S.N. Chapman, P. Mehndiratta, M.C. Johansen, T.L. McMurry, K.C. Johnston, and A.M. Southerland Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke Vasc. Health Risk Manag. 10 2014 75
4. A.R. Young, C. Ali, A. Duretête, and D. Vivien Neuroprotection and stroke: time for a compromise J. Neurochem. 103 2007 1302 1309
5. S. Liu, S.R. Levine, and H.R. Winn Targeting ischemic penumbra: part I-from pathophysiology to therapeutic strategy J. Exp. Stroke Transl. Med. 3 2010 47
6. H.L. Lutsep, and W.M. Clark Neuroprotection in acute ischaemic stroke Drugs R&D 1 1999 3 8
7. J.M. Peters, Y.M. Shah, and F.J. Gonzalez The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention Nat. Rev. Cancer 12 2012 181 195
8. K. Schoonjans, B. Staels, and J. Auwerx Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression J. Lipid Res. 37 1996 907 925
9. T. Ouk, C. Potey, S. Gautier, M. Bastide, D. Deplanque, B. Staels, and et al. PPARs: a potential target for a disease-modifying strategy in stroke Curr. Drug Targets 14 2013 752 767
10. Y.-C. Chen, J.-S. Wu, H.-D. Tsai, C.-Y. Huang, J.-J. Chen, G.Y. Sun, and et al. Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders Mol. Neurobiol. 46 2012 114 124
11. Q. Guo, G. Wang, X. Liu, and S. Namura Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice Brain Res. 1279 2009 121 130
12. M. Collino, M. Aragno, R. Mastrocola, E. Benetti, M. Gallicchio, C. Dianzani, and et al. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-α agonist WY14643 Free Radic. Biol. Med. 41 2006 579 589
13. Q. Guo, G. Wang, and S. Namura Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice J. Cereb. Blood Flow Metab. 30 2010 70 78
14. M.P. Pereira, O. Hurtado, A. Cárdenas, D. Alonso-Escolano, L. Boscá, J. Vivancos, and et al. The nonthiazolidinedione PPARγ agonist L-796,449 is neuroprotective in experimental stroke J. Neuropathol. Exp. Neurol. 64 2005 797 805
15. J. Culman, Y. Zhao, P. Gohlke, and T. Herdegen PPAR-γ: therapeutic target for ischemic stroke Trends Pharmacol. Sci. 28 2007 244 249
16. A. Iwashita, Y. Muramatsu, T. Yamazaki, M. Muramoto, Y. Kita, S. Yamazaki, and et al. Neuroprotective efficacy of the peroxisome proliferator-activated receptor δ-selective agonists in vitro and in vivo J. Pharmacol. Exp. Ther. 320 2007 1087 1096
17. K.-J. Yin, Z. Deng, M. Hamblin, J. Zhang, and Y.E. Chen Vascular PPARδ protects against stroke-induced brain injury Arterioscler. Thromb. Vasc. Biol. 31 2011 574 581
18. P. Gelé, V. Vingtdeux, C. Potey, H. Drobecq, A. Ghestem, P. Melnyk, and et al. Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke Proteome Sci. 12 2014 24
19. J. Zhou, J. Wu, X. Chen, N. Fortenbery, E. Eksioglu, K.N. Kodumudi, and et al. Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions Int. Immunopharmacol. 11 2011 890 898
20. Q.-h. Gong, Y. D-l, S. J-s, D. L-j, B. Liu, and L.-s. Li Advances in neuroharmacological effects and molecular mechanisms of icariin Chin. J. New Drugs Clin. Remedies 7 2011 003
21. Y. Luo, J. Nie, Q.H. Gong, Y.F. Lu, Q. Wu, and J.S. Shi Protective effects of icariin against learning and memory deficits induced by aluminium in rats Clin. Exp. Pharmacol. Physiol. 34 2007 792 795
22. F. Jin, Q.-H. Gong, Y.-S. Xu, L.-N. Wang, H. Jin, F. Li, and et al. Icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling Int. J. Neuropsychopharmacol. 17 2014 871 881
23. J. Nie, Y. Luo, X.-N. Huang, Q.-H. Gong, Q. Wu, and J.-S. Shi Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of β-secretase in rat hippocampus Eur. J. Pharmacol. 626 2010 213 218
24. F. Li, Q.-H. Gong, Q. Wu, Y.-F. Lu, and J.-S. Shi Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats Pharmacol. Biochem. Behav. 96 2010 301 305
25. L. Li, Q.-X. Zhou, and J.-S. Shi Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion Chin. Med. J. 118 2005 1637 1643
26. H.-r. Zhu, Z.-y. Wang, X.-l. Zhu, X.-x. Wu, L. E-g, and Y. Xu Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1α expression in experimental stroke Neuropharmacology 59 2010 70 76
27. S.-D. Chen, D.-I. Yang, T.-K. Lin, F.-Z. Shaw, C.-W. Liou, and Y.-C. Chuang Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia Int. J. Mol. Sci. 12 2011 7199 7215
28. Y.-F. Lu, Y.-Y. Xu, F. Jin, Q. Wu, J.-S. Shi, and J. Liu Icariin is a PPARα activator inducing lipid metabolic gene expression in mice Molecules 19 2014 18179 18191
29. B. Xing, H. Chen, M. Zhang, D. Zhao, R. Jiang, X. Liu, and et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat Stroke 39 2008 2362 2369
30. T. Horn, and J. Klein Neuroprotective effects of lactate in brain ischemia: dependence on anesthetic drugs Neurochem. Int. 62 2013 251 257
31. J.B. Bederson, L.H. Pitts, M. Tsuji, M.C. Nishimura, R.L. Davis, and H. Bartkowski Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination Stroke 17 1986 472 476
32. G. Yang, P.H. Chan, J. Chen, E. Carlson, S.F. Chen, P. Weinstein, and et al. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia Stroke 25 1994 165 170
33. Y. Xu, W. Zhang, J. Klaus, J. Young, I. Koerner, L.C. Sheldahl, and et al. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection Proc. Natl. Acad. Sci. 103 2006 14489 14494
34. M. Boyko, A. Zlotnik, B.F. Gruenbaum, S.E. Gruenbaum, S. Ohayon, T. Goldsmith, and et al. An experimental model of focal ischemia using an internal carotid artery approach J. Neurosci. Methods 193 2010 246 253
35. G.E. Hoffman, I. Merchenthaler, and S.L. Zup Neuroprotection by ovarian hormones in animal models of neurological disease Endocrine 29 2006 217 231
36. L.-J. Ding, J.-S. Shi, and Q.-H. Gong The effect of icariin on promoting neurogenesis and angiogenesis and its mechanism Zhongguo Yaolixue Dulixue Zazhi Chin. J. Pharmacol. Toxicol. 26 2012 437 438
37. C. Li, Q. Li, Q. Mei, and T. Lu Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii Life Sci. 126 2015 57 68
38. J. Guo, F. Li, Q. Wu, Q. Gong, Y. Lu, and J. Shi Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats Phytomedicine 17 2010 950 955
39. Y. Zhou, L. Yang, A. Ma, X. Zhang, W. Li, W. Yang, and et al. Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α Neuropharmacology 63 2012 242 249
40. A. Siniscalchi, L. Gallelli, G. Malferrari, D. Pirritano, R. Serra, E. Santangelo, and et al. Cerebral stroke injury: the role of cytokines and brain inflammation J. Basic Clin. Physiol. Pharmacol. 25 2014 131 137
41. M.K. Tobin, J.A. Bonds, R.D. Minshall, D.A. Pelligrino, F.D. Testai, and O. Lazarov Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here J. Cereb. Blood Flow Metab. 2014
42. A. Maddahi, and L. Edvinsson Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway J. Neuroinflammation 7 2010 14
43. F. Wan, and M.J. Lenardo The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives Cell Res. 20 2010 24 33
44. H. Li, J. Yin, L. Li, J. Deng, C. Feng, and Z. Zuo Isoflurane postconditioning reduces ischemia-induced nuclear factor-κB activation and interleukin 1β production to provide neuroprotection in rats and mice Neurobiol. Dis. 54 2013 216 224
45. K. Vaibhav, P. Shrivastava, H. Javed, A. Khan, M.E. Ahmed, R. Tabassum, and et al. Piperine suppresses cerebral ischemia-reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-κB in middle cerebral artery occlusion rat model Mol. Cell. Biochem. 367 2012 73 84
46. R. Bordet, T. Ouk, O. Petrault, P. Gele, S. Gautier, M. Laprais, and et al. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases Biochem. Soc. Trans. 34 2006 1341 1346
47. S. Aleshin, M. Strokin, M. Sergeeva, and G. Reiser Peroxisome proliferator-activated receptor (PPAR) β/δ, a possible nexus of PPARα-and PPARγ-dependent molecular pathways in neurodegenerative diseases: review and novel hypotheses Neurochem. Int. 63 2013 322 330
48. M.T. Heneka, and G.E. Landreth PPARs in the brain Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1771 2007 1031 1045
49. N.S. Wayman, Y. Hattori, M.C. McDonald, H. Mota-Filipe, S. Cuzzocrea, B. Pisano, and et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size FASEB J. 16 2002 1027 1040
50. M. Abdelrahman, A. Sivarajah, and C. Thiemermann Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock Cardiovasc. Res. 65 2005 772 781